X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf
https://www.fiercepharma.com/manufacturing/drug-mix-prompts-azurity-recall-1-lot-narcolepsy-drug-zenzedi
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-10-2024-93939.pdf
https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-acquires-slayback-pharma-301940279.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf
https://www.prnewswire.com/news-releases/brand-institute-partners-on-brand-name-development-for-fda-approved-treatment-for-active-benign-gastric-ulcer-and-reduction-of-risk-of-upper-gastrointestinal-bleeding-in-critically-ill-patients-301619274.html
https://endpts.com/azurity-pharmaceuticals-continues-its-win-streak-as-it-bags-another-approval-from-the-fda/
https://www.pharmaceutical-technology.com/news/fda-approval-azurity-konvomep/
https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-fda-approval-of-zonisade-zonisamide-oral-suspension-301587834.html
Market Place
Share 
